No substantial changes in C. difficile trends early in pandemic
Despite the changes and disruptions to care caused by COVID-19, researchers found that there were no significant changes in the incidence of Clostridioides difficile during…
Despite the changes and disruptions to care caused by COVID-19, researchers found that there were no significant changes in the incidence of Clostridioides difficile during…
The FDA has granted fast track designation to Pfizer for ervogastat in combination with clesacostat for treatment of patients with nonalcoholic steatohepatitis with liver fibrosis,…
SAN DIEGO — Paternal exposure to the majority of therapies for inflammatory bowel disease did not increase the risk for adverse neonatal outcomes, according to…
Women remain significantly underrepresented in academic internal medicine leadership positions in the United States, according to findings published in the Journal of General Internal Medicine.Underrepresentation…
SAN DIEGO — Though patients with inflammatory bowel disease have impaired humoral response after SARS-CoV-2 vaccinations, cellular responses were maintained and comparable to those of…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.